Growth Signaling

Vosoritide (Voxzogo)

FDA-approved product existsGH axis & hormones
Not yet scored

BioHarmony verdict

Awaiting review

No BioHarmony report yet. It is queued for review; until then, rely on the status and sources below.

What is Vosoritide (Voxzogo)?

FDA-approved vosoritide is marketed as Voxzogo to increase linear growth in pediatric patients with achondroplasia and open epiphyses.

Dosing as published

Approved labelVOXZOGO prescribing information for pediatric achondroplasia with open epiphyses
PopulationPediatric patients covered by the approved VOXZOGO indication
DoseWeight-based once-daily dosing from 0.096 mg to 0.8 mg according to the prescribing-information table
RouteSubcutaneous injection
FrequencyOnce daily
DurationUntil confirmation of no further growth potential, with weight and growth reassessed every 3 to 6 months
PreparationUse the entire supplied diluent syringe: 0.5 mL for the 0.4 mg vial, 0.7 mL for the 0.56 mg vial, or 0.6 mL for the 1.2 mg vial. Gently swirl; do not shake. Use within 3 hours and discard unused portion.
Source: Dosage and Administration sections 2.2-2.4; Dosage Forms and Strengths section 3

More reported protocols

Members

Members can compare additional reported doses, schedules, and preparation notes.

Trust & sourcing

US approvalFDA-approved product exists
CompoundingFDA-approved product exists; compounded copies are not FDA approved
Last checked2026-07-13
Next review2026-10-11

Primary sources

  1. 7.5/10TB-500 (Thymosin Beta-4 Fragment)Strong recommendRecoveryNot FDA approvedTB-500 is a synthetic LKKTETQ fragment marketed for soft-tissue repair, but most human evidence is on full-length topical thymosin beta-4: Sosne 2023 reported corneal…
  2. 6.4/10Kisspeptin-10Worth tryingGH & hormonesNot FDA approvedKisspeptin-10 is an investigational reproductive neuropeptide that activates the HPG axis through the KISS1R receptor.
  3. 6.3/10Gonadorelin (GnRH)Worth tryingGH & hormonesFDA-approved product existsGonadorelin is synthetic GnRH, a decapeptide that tells the pituitary to release LH and FSH.
  4. 6.2/10IpamorelinWorth tryingRecoveryNot FDA approvedIpamorelin is a selective growth-hormone secretagogue with strong receptor selectivity but almost no human efficacy data: its only completed human efficacy trial…

Free guide

The Ultimate Peptides Guide

Spot stronger candidates, weak evidence, and seller red flags before you buy.

Free. Includes evidence and regulatory updates. Unsubscribe anytime.